HBK Investments’s The Oncology Institute Warrant TOIIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-20,000
Closed -$32K 854
2021
Q3
$32K Sell
20,000
-38,599
-66% -$53.2K ﹤0.01% 700
2021
Q2
$101K Hold
58,599
﹤0.01% 737
2021
Q1
$79K Sell
58,599
-4,900
-8% -$9.09K ﹤0.01% 766
2020
Q4
$124K Hold
63,499
﹤0.01% 668
2020
Q3
$108K Sell
63,499
-56,461
-47% -$92.7K ﹤0.01% 608
2020
Q2
$176K Buy
+119,960
New +$172K ﹤0.01% 536

Other funds holding TOIIW

HBK Investments's TOIIW Position: Q1 2022 in Review

HBK Investments sold out of The Oncology Institute Warrant (TOIIW) in Q1 2022, closing a stake of 14,000 shares — an estimated $10K sold.

HBK Investments first reported a position in TOIIW in Q4 2021 and held it in 1 quarter. The position peaked at $10K in Q4 2021. 12 funds tracked by Wall St. Rank hold TOIIW as of Q1 2022.

  • HBK Investments reported no remaining The Oncology Institute Warrant position as of Q1 2022 after selling out during the quarter.
  • HBK Investments sold 14,000 The Oncology Institute Warrant shares in Q1 2022, an estimated $10K.
  • HBK Investments first reported a position in The Oncology Institute Warrant in Q4 2021 and held it in 1 quarter.
  • HBK Investments's The Oncology Institute Warrant position peaked at $10K in Q4 2021.
  • 12 funds tracked by Wall St. Rank held The Oncology Institute Warrant as of Q1 2022.

Based on HBK Investments's 13F filing for Q1 2022, filed 16 May 2022.